Log in to save to my catalogue

Angiogenesis in human brain tumors: screening of drug response through a patient-specific cell platf...

Angiogenesis in human brain tumors: screening of drug response through a patient-specific cell platf...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5993734

Angiogenesis in human brain tumors: screening of drug response through a patient-specific cell platform for personalized therapy

About this item

Full title

Angiogenesis in human brain tumors: screening of drug response through a patient-specific cell platform for personalized therapy

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2018-06, Vol.8 (1), p.8748-13, Article 8748

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Gliomas are the most common brain tumors, with diverse biological behaviour. Glioblastoma (GBM), the most aggressive and with the worst prognosis, is characterized by an intense and aberrant angiogenesis, which distinguishes it from low-grade gliomas (LGGs) and benign expansive lesions, as meningiomas (MNGs). With increasing evidence for the import...

Alternative Titles

Full title

Angiogenesis in human brain tumors: screening of drug response through a patient-specific cell platform for personalized therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5993734

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5993734

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-018-27116-7

How to access this item